Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome
Open Access
- 15 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 24 (1), 242-246
- https://doi.org/10.1038/leu.2009.210
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?Leukemia, 2009
- Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancyBlood, 2008
- Integrative analysis of RUNX1 downstream pathways and target genesBMC Genomics, 2008
- Cooperating gene mutations in acute myeloid leukemia: a review of the literatureLeukemia, 2008
- Normal and transforming functions of RUNX1: A perspectiveJournal of Cellular Physiology, 2006
- In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesisBlood, 2002
- A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignanciesBlood, 2001
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999